Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction.

Bennett CB, Westmoreland TJ, Verrier CS, Blanchette CA, Sabin TL, Phatnani HP, Mishina YV, Huper G, Selim AL, Madison ER, Bailey DD, Falae AI, Galli A, Olson JA, Greenleaf AL, Marks JR.

PLoS One. 2008 Jan 16;3(1):e1448. doi: 10.1371/journal.pone.0001448.

2.

Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.

Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF.

Cancer Res. 1998 Jan 1;58(1):65-70.

3.
4.

High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.

Verrier CS, Roodi N, Yee CJ, Bailey LR, Jensen RA, Bustin M, Parl FF.

Mol Endocrinol. 1997 Jul;11(8):1009-19.

PMID:
9212049
5.

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, Parl FF.

J Natl Cancer Inst. 1995 Mar 15;87(6):446-51.

PMID:
7861463
6.

Microsatellite instability and loss of heterozygosity in breast cancer.

Yee CJ, Roodi N, Verrier CS, Parl FF.

Cancer Res. 1994 Apr 1;54(7):1641-4.

Supplemental Content

Loading ...
Support Center